Top compounds associated with response to TDRP


Feature Type Standardized
Nominal ANOVA
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.071 0.08
mRNA Erlotinib CCLE pan-cancer AAC 0.091 0.08
mRNA Erlotinib CTRPv2 pan-cancer AAC 0.071 0.09
mRNA KW-2449 CTRPv2 pan-cancer AAC -0.061 0.09
mRNA BMS-536924 CTRPv2 pan-cancer AAC -0.073 0.09
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.072 0.09
mRNA AT-7519 GDSC1000 pan-cancer AAC -0.058 0.09
mRNA A-770041 GDSC1000 pan-cancer AAC -0.11 0.09
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.069 0.09
mRNA marinopyrrole A CTRPv2 pan-cancer AAC -0.091 0.09
Download CSV